Healthcare stocks with the fastest expected revenue growth

Ranked

53

of 876 healthcare stocks we cover

Median

+5.0%

Highest

+113.1%

INSM

Range

−12.3% to +113.1%

#	Company	Expected growth	Revenue growth (TTM)	Forward PE	Market cap
1	INSMInsmed, Biotechnology	+113.1%	+185.8%	n/m	$20.4B
2	WATWaters, Medical - Diagnostics & Research	+48.3%	+52.5%	29.2×	$44.6B
3	RPRXRoyalty Pharma, Medical - Pharmaceuticals	+37.2%	+10.0%	12.9×	$36.7B
4	ALNYAlnylam Pharmaceuticals, Biotechnology	+32.3%	+95.1%	26.7×	$30B
5	GHGuardant Health, Medical - Diagnostics & Research	+31.1%	+42.7%	n/m	$22.7B
6	REGNRegeneron Pharmaceuticals, Biotechnology	+20.4%	+9.3%	12.6×	$82.9B
7	LLYEli Lilly and, Drug Manufacturers - General	+18.6%	+49.6%	33.9×	$1.2T
8	ONCBeOne Medicines, Biotechnology	+17.8%	+34.3%	48.1×	$42.9B
9	NTRANatera, Medical - Diagnostics & Research	+15.6%	+37.8%	n/m	$58.2B
10	HUMHumana, Medical - Healthcare Plans	+13.7%	+18.3%	33.7×	$50.7B
11	ISRGIntuitive Surgical, Medical - Instruments & Supplies	+11.9%	+20.5%	37.5×	$159.8B
12	DXCMDexCom, Medical - Devices	+10.6%	+15.5%	27.7×	$29.4B
13	VRTXVertex Pharmaceuticals, Biotechnology	+10.6%	+10.2%	27.0×	$132.8B
14	DHRDanaher, Medical - Diagnostics & Research	+9.8%	+4.6%	25.4×	$162B
15	SYKStryker, Medical - Devices	+9.7%	+8.5%	19.3×	$117.8B
16	ABBVAbbVie, Drug Manufacturers - General	+8.8%	+10.4%	19.0×	$504.8B
17	EWEdwards Lifesciences, Medical - Devices	+8.5%	+14.6%	28.3×	$51.3B
18	IDXXIDEXX Laboratories, Medical - Diagnostics & Research	+7.6%	+12.8%	35.9×	$44.1B
19	STESTERIS, Medical - Specialties	+7.2%	+8.4%	20.2×	$22.6B
20	AAgilent Technologies, Medical - Diagnostics & Research	+6.7%	+8.6%	26.4×	$48.8B
21	JNJJohnson & Johnson, Drug Manufacturers - General	+6.7%	+7.8%	23.4×	$635.8B
22	MCKMcKesson, Medical - Distribution	+6.6%	+8.8%	21.6×	$116.7B
23	ILMNIllumina, Medical - Diagnostics & Research	+5.6%	+4.9%	47.2×	$40.7B
24	IQVIQVIA, Medical - Diagnostics & Research	+5.5%	+8.2%	20.5×	$46B
25	AMGNAmgen, Drug Manufacturers - General	+5.2%	+9.1%	18.6×	$237.5B
26	LHLabcorp, Medical - Diagnostics & Research	+5.2%	+6.4%	17.4×	$26.7B
27	BIIBBiogen, Drug Manufacturers - General	+5.0%	+0.3%	19.1×	$37B
28	TMOThermo Fisher Scientific, Medical - Diagnostics & Research	+5.0%	+8.3%	25.0×	$249.1B
29	MTDMettler-Toledo International, Medical - Diagnostics & Research	+4.7%	+6.9%	33.9×	$33.5B
30	CORCencora, Medical - Distribution	+4.5%	+5.1%	17.0×	$63.2B
31	CAHCardinal Health, Medical - Distribution	+4.5%	+14.2%	19.9×	$58B
32	GEHCGE HealthCare Technologies, Medical - Devices	+4.2%	+6.5%	13.8×	$32.3B
33	MDTMedtronic, Medical - Devices	+4.2%	+9.8%	15.9×	$122B
34	CICigna, Medical - Healthcare Plans	+3.8%	+7.8%	9.7×	$81.1B
35	GILDGilead Sciences, Drug Manufacturers - General	+3.6%	+5.5%	17.2×	$193.5B
36	WSTWest Pharmaceutical Services, Medical - Instruments & Supplies	+2.7%	+12.4%	42.2×	$27.6B
37	RMDResMed, Medical - Instruments & Supplies	+2.6%	+9.9%	20.8×	$36.5B
38	BSXBoston Scientific, Medical - Devices	+2.4%	+13.5%	14.1×	$66.2B
39	THCTenet Healthcare, Medical - Care Facilities	+2.3%	+5.4%	12.9×	$21.6B
40	HCAHCA Healthcare, Medical - Care Facilities	+2.3%	+7.3%	15.3×	$101.5B
41	CVSCVS Health, Medical - Healthcare Plans	+1.7%	+7.4%	11.5×	$119.5B
42	UNHUnitedHealth, Medical - Healthcare Plans	+1.7%	+3.3%	18.5×	$375.3B
43	MRKMerck, Drug Manufacturers - General	+1.6%	+4.6%	17.5×	$358.4B
44	INCYIncyte, Biotechnology	+1.6%	+26.9%	49.5×	$23.5B
45	UTHRUnited Therapeutics, Biotechnology	+0.6%	+2.5%	22.0×	$25.2B
46	BMYBristol-Myers Squibb, Drug Manufacturers - General	−0.4%	+3.1%	10.4×	$125.6B
47	ELVElevance Health, Medical - Healthcare Plans	−1.0%	+6.3%	16.1×	$95.4B
48	ZTSZoetis, Drug Manufacturers - Specialty & Generic	−2.8%	+1.5%	13.1×	$33.5B
49	PFEPfizer, Drug Manufacturers - General	−4.2%	−0.2%	10.9×	$171.2B
50	TEVATeva Pharmaceutical Industries, Drug Manufacturers - Specialty & Generic	−4.3%	+4.1%	14.1×	$45.9B
51	CNCCentene, Medical - Healthcare Plans	−5.6%	+13.9%	15.0×	$34.7B
52	BDXBecton, Dickinson and, Medical - Instruments & Supplies	−6.0%	+5.2%	15.1×	$54.2B
53	MRNAModerna, Biotechnology	−12.3%	−27.6%	n/m	$79.9B

Not ranked: 704 with not a meaningful number, 1 with expected growth from a base too small to compare, 1 with no revenue estimates. 117 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.